← FDA Drug Approvals (Drugs@FDA)
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2024-07-16
Drug application
- FDA Application #
ANDA215178- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
- Generic name
- DOXORUBICIN HYDROCHLORIDE
- Active ingredients
- DOXORUBICIN HYDROCHLORIDE
- Dosage form
- INJECTABLE, LIPOSOMAL
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- LUPIN
- Manufacturer
- BluePoint Laboratories
- First approval
- 2024-07-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown